Topical dexchlorpheniramine antihistamine that uses lipid solubility to enhance skin penetration: Began Phase IB/II dose-escalation trial

Arcturus Pharmaceutical Corp.,

Read the full 33 word article

How to gain access

Continue reading with a
two-week free trial.